Cargando…
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation
Successful discontinuation of tyrosine kinase inhibitors has been achieved in patients with chronic-phase chronic myeloid leukemia (CML). Careful molecular monitoring after discontinuation warrants safe and prompt resumption of therapy. We retrospectively evaluated how molecular monitoring has been...
Autores principales: | Dragani, Matteo, Rege Cambrin, Giovanna, Berchialla, Paola, Dogliotti, Irene, Rosti, Gianantonio, Castagnetti, Fausto, Capodanno, Isabella, Martino, Bruno, Cerrano, Marco, Ferrero, Dario, Gambacorti-Passerini, Carlo, Crugnola, Monica, Elena, Chiara, Breccia, Massimo, Iurlo, Alessandra, Cattaneo, Daniele, Galimberti, Sara, Gozzini, Antonella, Bocchia, Monica, Lunghi, Francesca, Cedrone, Michele, Sgherza, Nicola, Luciano, Luigia, Russo, Sabina, Santoro, Marco, Giai, Valentina, Caocci, Giovanni, Levato, Luciano, Abruzzese, Elisabetta, Sora, Federica, Saglio, Giuseppe, Fava, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698481/ https://www.ncbi.nlm.nih.gov/pubmed/33213044 http://dx.doi.org/10.3390/jcm9113692 |
Ejemplares similares
-
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice
por: Fava, Carmen, et al.
Publicado: (2019) -
Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey
por: Breccia, Massimo, et al.
Publicado: (2020) -
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper
por: Soverini, Simona, et al.
Publicado: (2019) -
Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study
por: Iurlo, Alessandra, et al.
Publicado: (2022) -
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study
por: Iurlo, A., et al.
Publicado: (2023)